Loading company…
Oxalo Therapeutics, Inc.
PrivateWon 4 federal SBIR/STTR research awards from NSF and other federal agencies.
National Science Foundation
- SAM UEI
- JD11RKB2KWJ3
- Founded
- —Source: [GOV]
- Headquarters
- Chicago, IllinoisSource: [GOV]
- Country
- United StatesSource: [GOV]
- Headcount
- 1Source: [GOV]
- Stage
$0Source: [GOV]Total raised
UndisclosedSource: [GOV]Last valuation
Overview
Oxalo Therapeutics, Inc. has been awarded 4 US Small Business Innovation Research (SBIR/STTR) contracts totalling $3,524,985 between 2018 and 2022. These are non-dilutive federal research grants, not equity financing. The company is based in Chicago, Illinois.
Funding rounds
4 rounds4 rounds · latest STTR Phase II award (NSF), Apr 2022
Sign in to see 4 rounds.
Sign inInvestors
No investors recorded yet for Oxalo Therapeutics, Inc..
Add an investorPeople
LeadershipSign in to see 1 more people.
Acquisitions
Oxalo Therapeutics, Inc. has no recorded acquisitions.
Add an acquisitionExits
Still private — no exit on record.
Record an exitDiversity investments
No diversity signals recorded yet for Oxalo Therapeutics, Inc..
Add diversity data